✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹9 Cr.
P/E
20.91
  • Dr Lalchandani Labs
  • DhanvantriJeevan Rek
  • Looks Health Service
FAQs on Dr Lalchandani Labs Ltd. Shareprice

Dr Lalchandani Labs has given better returns compared to its competitors.
Dr Lalchandani Labs has grown at ~-15.54% over the last 1yrs while peers have grown at a median rate of -18.0%

Dr Lalchandani Labs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Dr Lalchandani Labs is 20.91, while 3 year average PE is 11.17.
Also latest EV/EBITDA of Dr Lalchandani Labs is 0 while 3yr average is 13.75.

Growth Table
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Balance Sheet
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Cash Flow
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Quarterly Results
  • Dr Lalchandani Labs Ltd.
  • DhanvantriJeevan Rek
  • Looks Health Service
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Dr Lalchandani Labs Ltd. Financials

Balance sheet of Dr Lalchandani Labs is moderately strong.

The net debt of Dr Lalchandani Labs is decreasing.
Latest net debt of Dr Lalchandani Labs is ₹0.77 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1.28 Crs.

The profit is oscillating.
The profit of Dr Lalchandani Labs is ₹0.62 Crs for Mar 2024, -₹1.56 Crs for Mar 2023 and ₹0.93 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr Lalchandani Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech